欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
BNC105_945771-74-4_产品详情
945771-74-4
  • names:

    BNC105

  • CAS号:

    945771-74-4

    MDL Number:
  • MF(分子式): C20H20O7 MW(分子量): 372.37
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
BNC105
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002549-10mg 10mg 99.49% ¥ 6750.00 ¥ 6750.00 2-3天
- +
¥ 0.00
YZM002549-5mg 5mg 99.49% ¥ 4550.00 ¥ 4550.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 945771-74-4
Inchi
InchiKey
分子式 Formula C20H20O7
分子量 Molecular Weight 372.37
溶解度Solubility 生物体外In Vitro:DMSO溶解度25 mg/mL(67.14 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
BNC105(CAS:945771-74-4)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
IntroductionBNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
Application1
Application2
Application3
BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Flynn BL, et al. Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties. J Med Chem. 2011 Sep 8;54(17):6014-27.
【2】.Kremmidiotis G, et al. BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy. Mol Cancer Ther. 2010 Jun;9(6):1562-73.
【3】.Inglis DJ, et al. The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer. Cancer Biol Ther. 2014;15(11):1552-60.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents